Overview |
bs-1961R-PE-Cy5 |
ABI1 Polyclonal Antibody, PE-Cy5 Conjugated |
WB |
Rat |
Human, Mouse, Dog, Horse, Chicken, Rabbit |
Specifications |
PE-Cy5 |
Rabbit |
KLH conjugated synthetic peptide derived from human ABI1 |
101-200/508 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
10006 |
Q8IZP0 |
Cytoplasm, Nucleus, Cell membrane |
E3B1; ABI-1; ABLBP4; NAP1BP; SSH3BP; SSH3BP1; Abl interactor 1; Abelson interactor 1; Abl-binding protein 4; Eps8 SH3 domain-binding protein; Eps8-binding protein; Nap1-binding protein; Spectrin SH3 domain-binding protein 1; ABI1 |
May act in negative regulation of cell growth and transformation by interacting with nonreceptor tyrosine kinases ABL1 and/or ABL2. May play a role in regulation of EGF-induced Erk pathway activation. Involved in cytoskeletal reorganization and EGFR signaling. Together with EPS8 participates in transduction of signals from Ras to Rac. In vitro, a trimeric complex of ABI1, EPS8 and SOS1 exhibits Rac specific guanine nucleotide exchange factor (GEF) activity and ABI1 seems to act as an adapter in the complex. Regulates ABL1/c-Abl-mediated phosphorylation of ENAH. Recruits WASF1 to lamellipodia and there seems to regulate WASF1 protein level. In brain, seems to regulate the dendritic outgrowth and branching as well as to determine the shape and number of synaptic contacts of developing neurons. |
Application Dilution |
WB |
1:300-5000 |